Latest Insider Transactions at Brp Group, Inc. (BRP)
This section provides a real-time view of insider transactions for Brp Group, Inc. (BRP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRP Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRP Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+6.0%
|
-
|
|
Jul 01
2025
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+4.32%
|
-
|
|
Jul 01
2025
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+9.84%
|
-
|
|
Jul 01
2025
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+6.0%
|
-
|
|
Jul 01
2025
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+6.0%
|
-
|
|
Jul 01
2025
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+0.79%
|
-
|
|
Jul 01
2025
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+4.06%
|
-
|
|
Jul 01
2025
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
645
+4.06%
|
-
|
|
Jun 13
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
26,679
-38.78%
|
$1,067,160
$40.07 P/Share
|
|
Jun 12
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
10,894
-13.67%
|
$435,760
$40.03 P/Share
|
|
Jun 12
2025
|
Trevor Baldwin Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
117,000
-55.39%
|
$4,563,000
$39.89 P/Share
|
|
Jun 11
2025
|
Trevor Baldwin Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
58,000
-28.62%
|
$2,204,000
$38.48 P/Share
|
|
Jun 11
2025
|
Trevor Baldwin Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
175,000
+46.34%
|
-
|
|
Jun 11
2025
|
Trevor Baldwin Chief Executive Officer |
SELL
Conversion of derivative security
|
Indirect |
175,000
-8.26%
|
-
|
|
Jun 09
2025
|
Baldwin Insurance Group Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
50,000
-0.4%
|
-
|
|
Jun 09
2025
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
50,000
-100.0%
|
$1,900,000
$38.98 P/Share
|
|
Jun 09
2025
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
50,000
+50.0%
|
-
|
|
Jun 09
2025
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
50,000
-100.0%
|
-
|
|
Jun 09
2025
|
Lowry Baldwin Director |
BUY
Other acquisition or disposition
|
Indirect |
50,000
+50.0%
|
-
|
|
Jun 09
2025
|
Lowry Baldwin Director |
SELL
Other acquisition or disposition
|
Indirect |
50,000
-0.4%
|
-
|
|
Jun 04
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
7,142
-8.23%
|
$285,680
$40.08 P/Share
|
|
Jun 03
2025
|
Seth Bala Cohen General Counsel |
SELL
Open market or private sale
|
Direct |
4,496
-25.35%
|
$175,344
$39.58 P/Share
|
|
May 28
2025
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
62,500
-100.0%
|
$2,375,000
$38.32 P/Share
|
|
May 28
2025
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
62,500
+50.0%
|
-
|
|
May 28
2025
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
62,500
-100.0%
|
-
|
|
May 16
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
3,572
-3.95%
|
$142,880
$40.04 P/Share
|
|
May 15
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
14,222
-13.59%
|
$568,880
$40.01 P/Share
|
|
May 13
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
13,340
-11.31%
|
$533,600
$40.02 P/Share
|
|
May 13
2025
|
Daniel Galbraith Officer |
SELL
Open market or private sale
|
Direct |
39,207
-91.06%
|
$1,568,280
$40.0 P/Share
|
|
May 12
2025
|
Baldwin Insurance Group Holdings, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
155,000
-0.41%
|
-
|
|
May 12
2025
|
Lowry Baldwin Director |
SELL
Open market or private sale
|
Indirect |
62,500
-82.49%
|
$2,437,500
$39.09 P/Share
|
|
May 12
2025
|
Lowry Baldwin Director |
BUY
Conversion of derivative security
|
Indirect |
62,500
+50.0%
|
-
|
|
May 12
2025
|
Lowry Baldwin Director |
SELL
Conversion of derivative security
|
Indirect |
62,500
-50.0%
|
-
|
|
May 12
2025
|
Lowry Baldwin Director |
BUY
Other acquisition or disposition
|
Indirect |
125,000
+50.0%
|
-
|
|
May 12
2025
|
Lowry Baldwin Director |
SELL
Other acquisition or disposition
|
Indirect |
155,000
-0.41%
|
-
|
|
May 08
2025
|
James Morgan Roche Officer |
SELL
Open market or private sale
|
Direct |
21,035
-15.13%
|
$841,400
$40.05 P/Share
|
|
Apr 01
2025
|
Laura Sherman |
SELL
Other acquisition or disposition
|
Direct |
186
-12.3%
|
$7,998
$43.93 P/Share
|
|
Apr 01
2025
|
Corbyn N. Galloway Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
858
-1.8%
|
$36,894
$43.93 P/Share
|
|
Apr 01
2025
|
Seth Bala Cohen General Counsel |
SELL
Other acquisition or disposition
|
Direct |
98
-0.55%
|
$4,214
$43.93 P/Share
|
|
Apr 01
2025
|
Sunita Parasuraman Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+6.19%
|
-
|
|
Apr 01
2025
|
Ellyn Shook Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+6.19%
|
-
|
|
Apr 01
2025
|
Chris Thomas Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+0.77%
|
-
|
|
Apr 01
2025
|
Myron K Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+6.19%
|
-
|
|
Apr 01
2025
|
Jay A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+4.38%
|
-
|
|
Apr 01
2025
|
Joseph John Kadow Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+4.1%
|
-
|
|
Apr 01
2025
|
Barbara Ruth Matas Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+4.1%
|
-
|
|
Apr 01
2025
|
Sathish Muthukrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
624
+10.59%
|
-
|
|
Mar 17
2025
|
Daniel Galbraith Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-1.09%
|
$37,362
$39.97 P/Share
|
|
Mar 17
2025
|
Seth Bala Cohen General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-1.53%
|
$32,916
$39.97 P/Share
|
|
Mar 17
2025
|
James Morgan Roche Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-0.36%
|
$19,539
$39.97 P/Share
|